Q3 2024 |
30 |
$177M |
+$26M |
-$15.6M |
+$10.3M |
BFH, LNC, JXN, T, WAL
|
13F-HR |
11/14/2024, 11:06 AM |
Q2 2024 |
29 |
$157M |
+$15.9M |
-$15.7M |
+$238K |
BFH, T, JXN, LNC, WAL
|
13F-HR |
8/13/2024, 04:18 PM |
Q1 2024 |
30 |
$156M |
+$27.3M |
-$56.6M |
-$29.2M |
STLA, T, JXN, BFH, WAL
|
13F-HR |
5/7/2024, 11:23 AM |
Q4 2023 |
42 |
$168M |
+$12.6M |
-$25M |
-$12.4M |
STLA, WAL, UPRO, JXN, BFH
|
13F-HR |
2/14/2024, 01:24 PM |
Q3 2023 |
46 |
$159M |
+$27.2M |
-$24.7M |
+$2.48M |
STLA, JXN, WAL, QUAD, T
|
13F-HR |
11/14/2023, 03:00 PM |
Q2 2023 |
46 |
$152M |
+$22.9M |
-$1.48B |
-$1.46B |
UPRO, STLA, VTRS, OMF, CTO
|
13F-HR |
8/14/2023, 02:33 PM |
Q1 2023 |
90 |
$1.6B |
+$107M |
-$192M |
-$84.9M |
OMF, EXPE, AMZN, TMHC, GOOGL
|
13F-HR |
5/15/2023, 01:04 PM |
Q4 2022 |
79 |
$1.55B |
+$153M |
-$301M |
-$148M |
OVV, OMF, EXPE, TMHC, MAT
|
Restatement |
2/14/2023, 02:39 PM |
Q3 2022 |
87 |
$1.64B |
+$186M |
-$188M |
-$1.73M |
OVV, AMZN, EXPE, TEVA, MAT
|
13F-HR |
11/14/2022, 01:00 PM |
Q2 2022 |
83 |
$1.79B |
+$246M |
-$403M |
-$157M |
BABA, OVV, MAT, DXC, OMF
|
13F-HR |
8/15/2022, 01:05 PM |
Q1 2022 |
89 |
$2.64B |
+$232M |
-$265M |
-$33.2M |
AMZN, OVV, NCLH, DXC, SPLK
|
13F-HR |
5/16/2022, 12:01 PM |
Q4 2021 |
94 |
$2.83B |
+$431M |
-$409M |
+$22M |
AMZN, DXC, FANG, META, ADT
|
13F-HR |
2/14/2022, 01:08 PM |
Q3 2021 |
96 |
$2.94B |
+$248M |
-$649M |
-$400M |
AMZN, DXC, SPLK, GOOGL, META
|
13F-HR |
11/15/2021, 02:16 PM |
Q2 2021 |
100 |
$3.83B |
+$459M |
-$325M |
+$133M |
DXC, ADT, AMZN, BABA, OMF
|
13F-HR |
8/16/2021, 02:12 PM |
Q1 2021 |
94 |
$3.52B |
+$482M |
-$280M |
+$202M |
DXC, OMF, FTCHF, TEVA, AMZN
|
13F-HR |
5/17/2021, 12:00 PM |
Q4 2020 |
85 |
$2.96B |
+$499M |
-$811M |
-$312M |
FTCHF, DXC, AMZN, DM, SFIX
|
13F-HR |
2/16/2021, 02:08 PM |
Q3 2020 |
84 |
$2.53B |
+$371M |
-$375M |
-$3.67M |
FTCHF, AMZN, ADT, BABA, DXC
|
13F-HR |
11/16/2020, 10:51 AM |
Q2 2020 |
78 |
$2.25B |
+$264M |
-$213M |
+$51.6M |
FTCHF, AMZN, ADT, TEVA, META
|
13F-HR |
8/14/2020, 02:35 PM |
Q1 2020 |
73 |
$1.55B |
+$334M |
-$724M |
-$390M |
AMZN, TEVA, ADT, FTCHF, BABA
|
13F-HR |
5/15/2020, 11:02 AM |
Q4 2019 |
90 |
$2.8B |
+$227M |
-$296M |
-$69.2M |
ADT, BHC, AMZN, OMF, FLXN
|
13F-HR |
2/14/2020, 12:05 PM |
Q3 2019 |
96 |
$2.47B |
+$244M |
-$254M |
-$10.2M |
RH, AMZN, ADT, OMF, BHC
|
13F-HR |
11/14/2019, 09:13 AM |
Q2 2019 |
95 |
$2.5B |
+$248M |
-$306M |
-$58.1M |
AMZN, BHC, RH, OMF, ADT
|
13F-HR |
8/14/2019, 10:38 AM |
Q1 2019 |
100 |
$2.51B |
+$215M |
-$163M |
+$52.1M |
AMZN, BHC, OMF, RH, BHF
|
13F-HR |
5/15/2019, 01:29 PM |
Q4 2018 |
100 |
$2.19B |
+$92.3M |
-$210M |
-$118M |
AMZN, RH, GNW, BHC, OMF
|
13F-HR |
2/14/2019, 09:39 AM |
Q3 2018 |
108 |
$3.06B |
+$664M |
-$481M |
+$183M |
AMZN, ENDPQ, RH, BHC, OMF
|
13F-HR |
11/14/2018, 11:15 AM |
Q2 2018 |
109 |
$2.66B |
+$205M |
-$190M |
+$14.8M |
AMZN, RH, VRX, OMF, GNW
|
Restatement |
8/15/2018, 01:40 PM |
Q1 2018 |
107 |
$2.33B |
+$196M |
-$124M |
+$71.6M |
AMZN, RH, OMF, VRX, DAL
|
13F-HR |
5/15/2018, 11:42 AM |
Q4 2017 |
107 |
$2.31B |
+$229M |
-$171M |
+$57.5M |
VRX, AMZN, RH, OMF, DAL
|
13F-HR |
2/14/2018, 10:41 AM |
Q3 2017 |
106 |
$2.17B |
+$167M |
-$181M |
-$14.1M |
AMZN, RH, OMF, VRX, QUOT
|
13F-HR |
11/14/2017, 02:28 PM |
Q2 2017 |
110 |
$2.2B |
+$158M |
-$106M |
+$51.9M |
RH, VRX, AMZN, PAH, DAL
|
13F-HR |
8/14/2017, 10:06 AM |
Q1 2017 |
66 |
$1.93B |
+$361M |
-$315M |
+$45.7M |
RH, AMZN, PAH, OMF, LEN
|
13F-HR |
5/12/2017, 02:35 PM |
Q4 2016 |
57 |
$1.88B |
+$291M |
-$234M |
+$56.3M |
UAL, DAL, AAL, AMZN, MTG
|
13F-HR |
2/14/2017, 02:44 PM |
Q3 2016 |
61 |
$1.76B |
+$21.3M |
-$60.8M |
-$39.4M |
OMF, XON, QUOT, NXPI, DAL
|
13F-HR |
11/14/2016, 12:08 PM |
Q2 2016 |
62 |
$1.55B |
+$48.1M |
-$339M |
-$291M |
QUOT, LEN, PHM, XON, DAL
|
13F-HR |
8/15/2016, 11:52 AM |
Q1 2016 |
67 |
$2.01B |
+$183M |
-$590M |
-$407M |
DAL, XON, UAL, AAL, LEN
|
13F-HR |
5/16/2016, 11:51 AM |
Q4 2015 |
80 |
$2.61B |
+$375M |
-$115M |
+$259M |
DAL, AAL, UAL, LEN, XON
|
13F-HR |
2/16/2016, 10:35 AM |
Q3 2015 |
80 |
$2.35B |
+$187M |
-$123M |
+$64.5M |
DAL, P, XON, AAL, LEN
|
Restatement |
11/17/2015, 11:05 AM |
Q2 2015 |
88 |
$2.64B |
+$78.2M |
-$85M |
-$6.75M |
XON, MTG, DAL, AAL, NXPI
|
13F-HR |
8/14/2015, 10:43 AM |
Q1 2015 |
91 |
$2.65B |
+$194M |
-$199M |
-$5M |
XON, AAL, UAL, DAL, FCAU
|
13F-HR |
5/15/2015, 12:48 PM |
Q4 2014 |
94 |
$2.55B |
+$485M |
-$454M |
+$30.4M |
AAL, DAL, UAL, GNW, PHM
|
13F-HR |
2/17/2015, 01:00 PM |
Q3 2014 |
113 |
$2.36B |
+$231M |
-$261M |
-$29.4M |
DAL, UAL, AAL, QCOM, GILD
|
13F-HR |
11/14/2014, 10:00 AM |
Q2 2014 |
113 |
$2.49B |
+$205M |
-$218M |
-$12.8M |
AAL, DAL, GNW, QCOM, MTG
|
13F-HR |
8/14/2014, 02:10 PM |
Q1 2014 |
110 |
$2.49B |
+$335M |
-$55.9M |
+$279M |
GNW, DAL, AAL, NRF, QCOM
|
13F-HR |
5/15/2014, 01:44 PM |
Q4 2013 |
104 |
$2.15B |
$0 |
$0 |
|
GNW, MTG, DAL, NRF, NCT
|
13F-HR |
2/14/2014, 01:38 PM |